Results 221 to 230 of about 547,171 (369)

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism [PDF]

, 2011
Elisa Bellini, A. Pia, Maria Pia Brizzi, Marco Tampellini, M. Torta, Massimo Terzolo, Luigi Dogliotti, Alfredo Berruti   +7 more
openalex   +1 more source

Biomimetic Glycosaminoglycan‐Analog Hydrogel for Improved Embolization of Aneurysms: Environment‐Selective Swelling

Advanced Healthcare Materials, EarlyView.
Biomimetic glycosaminoglycan analog hydrogels exhibit suitable and robust mechanical properties, as well as hemocompatibility and biocompatibility, making them ideal for the embolization of intracranial aneurysms. Notably, the hydrogel's environment‐selective swelling properties enable complete blockage of the aneurysm cavity while preventing ...
Sarit S. Sivan, Iris Bonshtein, Maria Khoury, Yevgeniy Kreinin, Dmitry Korneyev, Tirosh Mekler, Sumaya Kaiyal, Iris Sonia Weitz, Netanel Korin   +8 more
wiley   +1 more source

Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23

Calcified Tissue International, 2020
N. Ito, M. Prideaux, Asiri R. Wijenayaka, Dongqing Yang, R. Ormsby, L. Bonewald, G. Atkins   +6 more
semanticscholar   +1 more source

The Link Between Estrogen and Fibroblast Growth Factor 23 [PDF]

, 2011
James B. Wetmore
openalex   +1 more source

Gasotransmitters in Modern Medicine: Promises and Challenges in the Use of Porous Crystalline Carriers

Advanced Healthcare Materials, EarlyView.
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto, Moisés L. Pinto, Christian Serre   +2 more
wiley   +1 more source

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation [PDF]

, 2011
Geeta Hampson
openalex   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source

Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis

, 2008
Katherine Wesseling‐Perry, Renata C. Pereira, Hong Wang, Robert M. Elashoff, Shobha Sahney, Barbara Gales, Harald Jüppner, Isidro B. Salusky   +7 more
openalex   +1 more source

Excess fibroblast growth factor 23 in alcoholic osteomalacia is derived from the bone. [PDF]

JBMR Plus
Hidaka N, Oyama Y, Koga M, Kondo N, Yasunaga Y, Shimakura T, Yamamoto N, Takahashi HE, Iwafuchi Y, Watanabe S, Kimura S, Hoshino Y, Kato H, Kinoshita Y, Kobayashi H, Tanaka T, Ushiku T, Nangaku M, Tanaka S, Makita N, Saito T, Ito N.   +21 more
europepmc   +1 more source

Fibroblast growth factor 23, klotho and heparin. [PDF]

Curr Opin Nephrol Hypertens, 2023
Thomas SM, Li Q, Faul C.
europepmc   +1 more source